NasdaqCM - Nasdaq Real Time Price USD

Fennec Pharmaceuticals Inc. (FENC)

8.32
-0.11
(-1.25%)
As of 9:42:53 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
30,912
47,538
21,252
1,535
0
Cost of Revenue
3,007
3,184
1,259
86
0
Gross Profit
27,905
44,354
19,993
1,449
0
Operating Expense
39,888
41,786
32,764
24,038
17,223
Operating Income
-11,983
2,568
-12,771
-22,589
-17,223
Net Non Operating Interest Income Expense
-1,988
-2,476
-3,240
-932
-88
Other Income Expense
-102
-163
-34
-193
-35
Pretax Income
-14,073
-71
-16,045
-23,714
-17,346
Tax Provision
--
365
0
--
--
Net Income Common Stockholders
-14,438
-436
-16,045
-23,714
-17,346
Diluted NI Available to Com Stockholders
-14,438
-436
-16,045
-23,714
-17,346
Basic EPS
-0.53
-0.02
-0.60
-0.90
-0.67
Diluted EPS
-0.53
-0.02
-0.60
-0.90
-0.67
Basic Average Shares
27,427.25
27,294
26,574
26,275
26,006
Diluted Average Shares
27,427.25
27,294
26,574
26,275
26,006
Total Operating Income as Reported
-11,983
2,568
-12,771
-22,589
-17,223
Total Expenses
42,895
44,970
34,023
24,124
17,223
Net Income from Continuing & Discontinued Operation
-14,438
-436
-16,045
-23,714
-17,346
Normalized Income
-14,336
-307.23
-16,011
-23,521
-17,311
Interest Income
1,721
1,682
441
195
54
Interest Expense
3,627
4,069
3,394
978
126
Net Interest Income
-1,988
-2,476
-3,240
-932
-88
EBIT
-10,446
3,998
-12,651
-22,736
-17,220
EBITDA
-10,343
4,798
-12,651
-22,736
-17,220
Reconciled Cost of Revenue
3,007
3,184
1,259
86
0
Reconciled Depreciation
103
800
0
149
16
Net Income from Continuing Operation Net Minority Interest
-14,438
-436
-16,045
-23,714
-17,346
Total Unusual Items Excluding Goodwill
-102
-163
-34
-193
-35
Total Unusual Items
-102
-163
-34
-193
-35
Normalized EBITDA
-10,241
4,961
-12,617
-22,543
-17,185
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-34.23
0
0
0
12/31/2021 - 9/15/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EPRX Eupraxia Pharmaceuticals Inc.
3.9200
0.00%
 
WHWK Whitehawk Therapeutics, Inc.
1.8900
+1.07%
 
HOOK HOOKIPA Pharma Inc.
1.5400
-1.28%
 
456070.KQ ENCell
12,930.00
+1.49%
 
HLOSF Healios K.K.
3.1700
0.00%
 
MEB.F MedinCell S.A.
15.47
-1.40%
 
BIX0.F BioInvent International AB (publ)
3.5050
+3.70%
 
RFM.F Sensorion SA
0.4000
+6.67%
 
2LB.F Iovance Biotherapeutics, Inc.
1.9476
+25.68%
 
RZLT Rezolute, Inc.
4.3650
-1.47%